Want to create an interactive transcript for this episode?
Podcast: The Money with Katie Show
Episode: The Economics of Weight Loss Drugs, Thinness, and Class Signaling
Description: We’ve all heard about Ozempic. But there are the GLP-1s we colloquially call “Ozempic” (see also: Wegovy, Mounjaro, Zepbound) and then there’s the cultural role of Ozempic. Given the price of these drugs, barriers to access, and class implications of weight stigma, this topic presents a unique opening to talk about inequality in health outcomes and the profitable business of individualizing social problems.In part one of this rare two-part series, we’re covering:
The wage penalties associated with (and relationship between) weight and women, and the par...